On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine.
Miller
R
R
Department of Anatomy, University of Otago Medical School, Dunedin, New Zealand.
Beninger
R J
RJ
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology; D003342:Corpus Striatum / Q000502:physiology*; D004292:Dominance, Cerebral; D004298:Dopamine / Q000502:physiology*; D015259:Dopamine Agents / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004347:Drug Interactions; D007839:Functional Laterality / Q000502:physiology*; D008124:Locomotion / Q000187:drug effects / Q000502:physiology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology; D010627:Phenethylamines / Q000494:pharmacology; D011187:Posture / Q000502:physiology*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D012201:Reward; D013239:Stereotyped Behavior / Q000187:drug effects / Q000502:physiology
D001552:Benzazepines; D015259:Dopamine Agents; D018492:Dopamine Antagonists; D010627:Phenethylamines; D011954:Receptors, Dopamine; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; C016868:N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride; D000661:Amphetamine; D001058:Apomorphine; D004298:Dopamine